M-Marsel Mesulam

17PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

|Dec 16, 2025
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel.

Mark W Youngblood, Abha Kumari, Yoon-Tae Kang

|Oct 03, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.

Derek Wainwright, Rimas Lukas, Lijie Zhai

|Jun 11, 2025
Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.

Karl J Habashy, Timothy W Synold, Ye Feng

|Feb 13, 2025
Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis.

Conor B Driscoll, Jordan M Rich, Dylan Isaacson

|Feb 03, 2025
Development and Validation of Risk Stratification for Heart Failure After Acute Coronary Syndrome Based on Dynamic S100A8/A9 Levels.

Jie Ma, Ke Ma, Jing Chen

Pageof 3

Frequent Collaborators

6 joint publications

Adam Sonabend

6 joint publications

Roger Stupp

4 joint publications

Crismita Dmello

3 joint publications

Priya Kumthekar